Design, synthesis and evaluation of targeted hypoxia-activated prodrugs applied to chondrosarcoma chemotherapy-Reference-Cited by-同舟云学术

Design, synthesis and evaluation of targeted hypoxia-activated prodrugs applied to chondrosarcoma chemotherapy

Published:2020-05 Issue: Volume:98 Page:103747
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Gerard Yvain,Voissière Aurélien,Peyrode Caroline,Galmier Marie-Josephe,Maubert Elise,Ghedira Donia,Tarrit Sebastien,Gaumet Vincent,Canitrot Damien,Miot-Noirault Elisabeth,Chezal Jean-Michel,Weber Valérie

Funder

Institut National Du Cancer

Ligue Contre le Cancer

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference60 articles.

1. The clinical approach towards chondrosarcoma;Gelderblom;Oncologist,2008

2. Surmounting chemotherapy and radioresistance in chondrosarcoma: molecular mechanisms and therapeutic targets;Onishi;Sarcoma,2011

3. Increased levels of hypoxia-inducible factor-1α are associated with Bcl-xL expression, tumor apoptosis, and clinical outcome in chondrosarcoma;Chen;J. Orthop. Res.,2011

4. Correlation of hypoxic signalling to histological grade and outcome in cartilage tumours;Boeuf;Histopathology,2010

5. Novel therapeutic approaches in chondrosarcoma;Polychronidou;Future Oncol.,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the Synthesis of Biologically Active Quaternary Ammonium Compounds;International Journal of Molecular Sciences;2024-04-24

2. Nitroimidazole-sulfonamides as carbonic anhydrase IX and XII inhibitors targeting tumor hypoxia: Design, synthesis, molecular docking and molecular dynamics simulation;Journal of Molecular Structure;2022-09

3. Design, Synthesis, and Biological Evaluation of Artemisinin‐Piperazine‐Phosphoramide Mustard Hybrids as Potential Anticancer Agents;ChemMedChem;2022-07-13

4. Nitroaromatic Hypoxia-Activated Prodrugs for Cancer Therapy;Pharmaceuticals;2022-02-02

5. Development of hypoxia-activated PROTAC exerting a more potent effect in tumor hypoxia than in normoxia;Chemical Communications;2021